Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kynmobi for Refractory Restless Legs Syndrome
NCT05529095Phase 4Unknown
- Start
- Sep 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apomorphine in restless legs syndrome (RLS). Status: unknown.
02
Drugs
apomorphine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT05529095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05529095.